Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MEDIFAST INC Director's Dealing 2020

Jun 8, 2020

33899_dirs_2020-06-08_193888b0-c958-40bc-8189-209380aa9cd5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2020-06-04

Reporting Person: SCHLACKMAN SCOTT (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-06-04 Common Stock M 1500.00 $27.68 Acquired 7555.00 Direct
2020-06-04 Common Stock S 1619.00 $107.35 Disposed 5936.00 Direct
2020-06-04 Common Stock S 1500.00 $107.77 Disposed 4436.00 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-06-04 Stock Option (Right to Buy) $27.68 M 1500.00 Disposed 2026-02-04 Common Stock (1500.00) Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.28 to $107.46, inclusive.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.47 to $107.79, inclusive.

F3: These stock options, which were issued to the reporting person under the 2012 Share Incentive Plan, vested and became non-forfeitable on each of the first, second and third anniversaries of the Grant Date subject to the requirements of the Plan and Award Agreement beginning on 04-Feb-2016.